Which of the following medications do not worsen hypertension: cyclosporine, amiodarone, erythropoietin, contraceptives (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs))?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone Does NOT Worsen Hypertension

Among the medications listed, amiodarone is the only agent that does not worsen hypertension. The other four medications—cyclosporine, erythropoietin, contraceptives, and NSAIDs—are all well-established blood pressure-elevating agents according to major hypertension guidelines.

Medications That DO Worsen Hypertension

Cyclosporine

  • Cyclosporine causes a dose-dependent increase in blood pressure that is both statistically and clinically significant 1.
  • Lower doses (1-4 mg/kg/day) increase mean blood pressure by approximately 5 mmHg, while higher doses (>10 mg/kg/day) increase it by 11 mmHg on average 2.
  • The ACC/AHA guidelines recommend considering conversion to tacrolimus in hypertensive patients, as it may have fewer effects on blood pressure 1.
  • This blood pressure elevation increases cardiovascular risk including stroke, myocardial infarction, and heart failure 2.

Erythropoietin

  • Erythropoietin is explicitly listed as a drug-induced cause of elevated blood pressure in the JNC 7 guidelines 1.
  • The ACC/AHA 2017 guidelines also identify erythropoietin as a medication that can cause elevated blood pressure 1.

Oral Contraceptives

  • Combined oral contraceptives cause small but significant increases in blood pressure, with overt hypertension developing in approximately 5% of users 3, 4.
  • High-dose estrogen formulations can increase blood pressure by 6/3 mmHg 3.
  • The ACC/AHA recommends using low-dose (20-30 mcg ethinyl estradiol) agents or progestin-only forms of contraception, and avoiding use in women with uncontrolled hypertension 1, 3.
  • The estrogenic component appears to be the primary factor producing abnormalities in the renin-angiotensin-aldosterone system 4.

NSAIDs

  • NSAIDs are consistently identified as blood pressure-elevating agents that should be avoided or limited in hypertensive patients 1.
  • Meta-analyses show NSAIDs increase mean arterial pressure by approximately 5 mmHg 5.
  • The 2020 ISH guidelines specifically recommend avoiding high doses of NSAIDs in patients with inflammatory rheumatic diseases and hypertension 1.
  • NSAIDs can reduce the efficacy of several antihypertensive drugs including diuretics, beta-blockers, and ACE inhibitors through prostaglandin inhibition 6, 5.
  • When analgesics are necessary, acetaminophen may be preferable to NSAIDs in patients with resistant hypertension 1.

Amiodarone: The Exception

Amiodarone is not mentioned in any major hypertension guideline as a blood pressure-elevating agent 1. Unlike the other medications listed, it does not appear in the comprehensive tables of drugs that cause elevated blood pressure in the ACC/AHA or JNC guidelines.

Clinical Implications

  • When evaluating resistant hypertension, the 2020 ISH guidelines emphasize excluding substance-induced increases in blood pressure as a first step 1.
  • The ACC/AHA recommends screening all hypertensive patients for medications that may raise blood pressure or interfere with antihypertensive therapy 1, 7.
  • Blood pressure should be monitored closely when initiating any of the blood pressure-elevating agents, with recognition that adjustments to the antihypertensive regimen may become necessary 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effect of cyclosporine on blood pressure.

The Cochrane database of systematic reviews, 2010

Guideline

Lynestrenol and Blood Pressure Elevation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral contraceptives--induced hypertension--nine years later.

American journal of obstetrics and gynecology, 1976

Guideline

Medications That Contribute to Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.